Limei Yao

517 total citations
30 papers, 405 citations indexed

About

Limei Yao is a scholar working on Complementary and alternative medicine, Genetics and Molecular Biology. According to data from OpenAlex, Limei Yao has authored 30 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Complementary and alternative medicine, 7 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Limei Yao's work include Traditional Chinese Medicine Analysis (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Limei Yao is often cited by papers focused on Traditional Chinese Medicine Analysis (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Limei Yao collaborates with scholars based in China and Macao. Limei Yao's co-authors include Rui‐Xing Yin, Yang Dezhai, Shang‐Ling Pan, Xi Li, Jin‐Zhen Wu, Xinwei Su, Chen Yu-ming, Lin Weixiong, Tangwei Liu and Weirong Li and has published in prestigious journals such as Scientific Reports, Journal of Ethnopharmacology and BioMed Research International.

In The Last Decade

Limei Yao

30 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limei Yao China 11 94 90 81 75 50 30 405
Ting-I Lee Taiwan 12 133 1.4× 164 1.8× 164 2.0× 53 0.7× 17 0.3× 33 547
Sotoodeh Abhary Australia 13 62 0.7× 72 0.8× 195 2.4× 40 0.5× 65 1.3× 24 729
Armand Krikorian United States 10 140 1.5× 21 0.2× 121 1.5× 61 0.8× 20 0.4× 16 393
Susan Stephenson United States 13 200 2.1× 138 1.5× 69 0.9× 231 3.1× 57 1.1× 22 585
Xuan Luo China 11 50 0.5× 33 0.4× 173 2.1× 50 0.7× 15 0.3× 23 462
Jeroen B. van der Net Netherlands 13 78 0.8× 56 0.6× 86 1.1× 144 1.9× 104 2.1× 17 423
Xuehan Zhou United States 14 82 0.9× 205 2.3× 175 2.2× 96 1.3× 38 0.8× 25 792
Joshua N. Curry United States 10 130 1.4× 68 0.8× 386 4.8× 43 0.6× 24 0.5× 13 705
Lei Hou China 14 66 0.7× 71 0.8× 179 2.2× 50 0.7× 87 1.7× 38 525
Yurong Wang China 13 49 0.5× 53 0.6× 67 0.8× 100 1.3× 17 0.3× 36 449

Countries citing papers authored by Limei Yao

Since Specialization
Citations

This map shows the geographic impact of Limei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Yao more than expected).

Fields of papers citing papers by Limei Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Yao. The network helps show where Limei Yao may publish in the future.

Co-authorship network of co-authors of Limei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Limei Yao. A scholar is included among the top collaborators of Limei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Yao. Limei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Yingying, Qi Shen, Wei Zhao, et al.. (2025). UHPLC-Q Exactive-Orbitrap-MS and network pharmacology analyses to investigate the mechanism by which Danggui-Shaoyao-San affects 27-OHC-induced cell damage in SH-SY5Y/C6 coculture. BMC Complementary Medicine and Therapies. 25(1). 75–75. 1 indexed citations
2.
Shen, Qi, et al.. (2024). Drug Interactions between Traditional Chinese Medicines and Cardiovascular Drugs. European Journal of Drug Metabolism and Pharmacokinetics. 49(5). 559–582. 2 indexed citations
3.
Chen, Wei‐Chun, Qi Shen, Limei Yao, et al.. (2023). Comparative Study on the Pharmacokinetics of Paeoniflorin, White Peony Root Water Extract, and Taohong Siwu Decoction After Oral Administration in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 48(3). 301–310. 2 indexed citations
4.
5.
Huang, Jiawen, Xiangyu Wang, Wei Zhao, et al.. (2020). Extract of Danggui-Shaoyao-San ameliorates cognition deficits by regulating DHA metabolism in APP/PS1 mice. Journal of Ethnopharmacology. 253. 112673–112673. 26 indexed citations
6.
Wang, Xiaoge, Jiawen Huang, Wei Zhao, et al.. (2019). Effects of Xingnaojing Injection on Adenosinergic Transmission and Orexin Signaling in Lateral Hypothalamus of Ethanol-Induced Coma Rats. BioMed Research International. 2019. 1–11. 3 indexed citations
7.
Yin, Rui‐Xing, et al.. (2019). Correlation Between the APOB rs1042034 SNP and Blood Lipid Characteristics of 2 Ethnic Groups in China. Clinical and Applied Thrombosis/Hemostasis. 25. 2873290616–2873290616. 5 indexed citations
8.
Jia, Xingyuan, Limei Yao, Yan Zhou, et al.. (2018). Detection of three common mutations causing β-thalassemia by using a closed-tube multiplex PCR. Experimental and Molecular Pathology. 105(2). 208–212. 2 indexed citations
9.
10.
Yao, Limei, et al.. (2017). Hepatocellular toxicity of oxalicumone A via oxidative stress injury and mitochondrial dysfunction in healthy human liver cells. Molecular Medicine Reports. 17(1). 743–752. 9 indexed citations
11.
Yin, Rui‐Xing, et al.. (2016). Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels. Scientific Reports. 6(1). 19079–19079. 27 indexed citations
12.
Shi, Yongtang, Youliang Zhang, Limei Yao, et al.. (2016). Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization. Heart and Vessels. 31(11). 1776–1782. 28 indexed citations
13.
Yin, Rui‐Xing, Limei Yao, Feng Huang, et al.. (2016). Integrative mutation, haplotype and G × G interaction evidence connects ABGL4, LRP8 and PCSK9 genes to cardiometabolic risk. Scientific Reports. 6(1). 37375–37375. 7 indexed citations
14.
Yao, Limei, Lei Yang, Wei Zhao, et al.. (2015). Alteration of glutamate/GABA balance during acute alcohol intoxication in rats: Effect of Xingnaojing injection. Journal of Ethnopharmacology. 166. 333–339. 18 indexed citations
15.
Jia, Xingyuan, Rui Huang, Limei Yao, et al.. (2013). Detection of a novel large deletion causing α-thalassemia in South China. Experimental and Molecular Pathology. 95(1). 68–73. 7 indexed citations
16.
Yao, Limei, et al.. (2013). Therapeutic efficacy observation on combining intermittent traction with warm needling for cervical radiculopathy. Journal of Acupuncture and Tuina Science. 11(6). 367–370. 4 indexed citations
17.
Yao, Limei. (2011). Potential targets and molecular mechanisms of "Xiaochaihu Decoction" by Metadrug software. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations
18.
Yin, Rui‐Xing, Limei Yao, Chen Yu-ming, et al.. (2006). Prevalence, Awareness, Treatment, Control and Risk Factors of Hypertension in the Guangxi Hei Yi Zhuang and Han Populations. Hypertension Research. 29(6). 423–432. 47 indexed citations
19.
Yin, Rui‐Xing, Chen Yu-ming, Shang‐Ling Pan, et al.. (2006). Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. European Journal of Cardiovascular Prevention & Rehabilitation. 13(6). 977–984. 59 indexed citations
20.
Yao, Limei. (2004). American Transcendentalism and Chinese Classical Philosophical Thoughts. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting-I Lee Breakdown of academic impact, for papers by Sotoodeh Abhary Breakdown of academic impact, for papers by Armand Krikorian Breakdown of academic impact, for papers by Susan Stephenson Breakdown of academic impact, for papers by Xuan Luo Breakdown of academic impact, for papers by Jeroen B. van der Net Breakdown of academic impact, for papers by Xuehan Zhou Breakdown of academic impact, for papers by Joshua N. Curry Breakdown of academic impact, for papers by Lei Hou Breakdown of academic impact, for papers by Yurong Wang
Rankless by CCL
2026